Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07219498 · ClinicalTrials.gov registry record · NA

Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness

A NA study of Delayed Onset Muscle Soreness (DOMS) and Exercise Induced Muscle Damage, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT07219498 is a NA study of Delayed Onset Muscle Soreness (DOMS) and Exercise Induced Muscle Damage that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07219498, a NA study of Delayed Onset Muscle Soreness (DOMS) and Exercise Induced Muscle Damage, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate how probiotic supplementation (PS) influences post-exercise recovery in healthy, physically active young adults. Researchers aim to determine if the Lactobacillus casei probiotic strain reduces symptoms of delayed onset muscle soreness (DOMS) based on perceived muscle soreness, pressure pain threshold, and power output following exercise induced muscle damage (EIMD).

Interventions

  • DIETARY_SUPPLEMENT Lactobacillus casei
  • OTHER Placebo Capsule(s)

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2026-02-05
Est. Completion 2026-04-30
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT07219498

The ClinicalTrials.gov registry entry for NCT07219498 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Delayed Onset Muscle Soreness (DOMS) appearing as the primary indexed condition, and to 2 interventions - of which Lactobacillus casei is the first listed.

NCT07219498 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07219498 about?

NCT07219498 is a clinical study titled "Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness". The purpose of this study is to evaluate how probiotic supplementation (PS) influences post-exercise recovery in healthy, physically active young adults. Researchers aim to determine if the Lactobacillus casei probiotic strain reduces symptoms of delayed onset muscle soreness (DOMS) based on perceiv...

What is the current status of trial NCT07219498?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-02-05. Estimated completion is 2026-04-30.

What conditions does trial NCT07219498 study?

This clinical trial studies the following conditions: Delayed Onset Muscle Soreness (DOMS), Exercise Induced Muscle Damage.

What interventions are being tested in trial NCT07219498?

The interventions under investigation include: Lactobacillus casei (DIETARY_SUPPLEMENT), Placebo Capsule(s) (OTHER).

Who is sponsoring clinical trial NCT07219498?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07219498 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delayed Onset Muscle Soreness (DOMS)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.